Abstract
Hypertension is an important public health problem, and increasingly children are being diagnosed with primary hypertension. As the list of secondary causes of hypertension is extensive, pediatric practitioners increasingly need to decide on investigations needed for evaluating children presenting with high blood pressure. The differentiation between primary and secondary hypertension is paramount to understanding this important health issue, since many forms of secondary hypertension require specific treatment. The review evaluates the current available guidelines and practice patterns for evaluating children with elevated blood pressure. The review also aims to provide a framework for cost-effective evaluation strategies for children with elevated blood pressure based on current recommendations and evidence.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Din-Dzietham R, Liu Y, Bielo MV, Shamsa F. High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation. 2007;116(13):1488–96.
• Flynn J. The changing face of pediatric hypertension in the era of the childhood obesity epidemic. Pediatr Nephrol. 2012. Review discussing the changing etiology of pediatric hypertension. The review highlights the importance of identifying the growing pediatric populations of patients with primary hypertension.
• Kapur G, Ahmed M, Pan C, Mitsnefes M, Chiang M, Mattoo TK. Secondary hypertension in overweight and stage 1 hypertensive children: a Midwest Pediatric Nephrology Consortium report. J Clin Hypertens (Greenwich). 2010;12(1):34–9. Multicenter study reporting on the existing variability in evaluation of children with hypertension. The study also highlights the potential limitations of evaluation decisions based on hypertension stages as recommended in the fourth Task Force report.
Kapur G, Mattoo TK. Primary hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 342–56.
•• National High Blood Pressure Education Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114(2 Suppl 4th Report):555–76. The recommendations by an expert panel are universally accepted guidelines on pediatric hypertension. They also propose stratifying evaluation based on hypertension staging in order to develop a more cost-effective approach to evaluation of hypertension in children.
Butani LMB. Casual blood pressure methodology. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 113–34.
Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45(1):142–61.
• Flynn JT. Ambulatory blood pressure monitoring in children: imperfect yet essential. Pediatr Nephrol. 2011;26(12):2089–94. Review on ABPM in children.
• Flynn JT, Urbina EM. Pediatric ambulatory blood pressure monitoring: indications and interpretations. J Clin Hypertens (Greenwich). 2012;14(6):372–82. Review on ABPM in children.
•• Lurbe E, Cifkova R, Cruickshank JK, Dillon MJ, Ferreira I, Invitti C, et al. Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–42. Recommendations by an expert panel on pediatric hypertension. The sections on the evaluation of target organ damage and low renin hypertension in children with elevated blood pressure are comprhensive and helpful in clinical decision making.
•• Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: recommendations for standard assessment: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension. 2008;52(3):433–51. Accepted norms for ABPM interpretation in children.
Flynn JT. Differentiation between primary and secondary hypertension in children using ambulatory blood pressure monitoring. Pediatrics. 2002;110(1 Pt 1):89–93.
Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.
Lee SH, Kim JH, Kang MJ, Lee YA, Won Yang S, Shin CH. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care. 2011;34(10):2180–5.
Seeman T, Palyzova D, Dusek J, Janda J. Reduced nocturnal blood pressure dip and sustained nighttime hypertension are specific markers of secondary hypertension. J Pediatr. 2005;147(3):366–71. Epub 2005/09/27.
Swartz SJ, Srivaths PR, Croix B, Feig DI. Cost-effectiveness of ambulatory blood pressure monitoring in the initial evaluation of hypertension in children. Pediatrics. 2008;122(6):1177–81. Epub 2008/12/03.
Flynn E, Flavin A. General practitioner's reported use of clinical guidelines for hypertension and ambulatory blood pressure. Irish Med J. 2012;105(3):89–91. Epub 2012/05/09.
• Kapur G. What do I need to know to start ambulatory blood pressure monitoring for children with hypertension? Available at http://www2.aap.org/sections/nephrology/NephrologyNewsletterSummer2012.pdf Accessed 05/2013. Review focusing on information needed to start ABPM in a pediatric setting. The review also elaborates on the factors leading to limited use of ABPM which is universally recommended by experts as being indispensible for hypertension evaluation in children.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA: J Am Med Assoc. 2003;289(19):2560–72. Epub 2003/05/16.
Kaplan N. Initial evaluation of the hypertensive adult. Available at http://www.uptodate.com/contents/initial-evaluation-of-the-hypertensive-adult Accessed 05/2013.
•• Baracco R, Kapur G, Mattoo T, Jain A, Valentini R, Ahmed M, et al. Prediction of primary vs secondary hypertension in children. J Clin Hypertens (Greenwich). 2012;14(5):316–21. A retrospective study reporting the limitations of routine testing for thyroid funtion tests, plasma renin activity, serum aldosterone and urinary catecholamines in children. The study also reports on increased risk for secondary hypertension in children <12 years old and hypertensive children with an abnormal renal ultrasound.
• Brewer ED. Evaluation of hypertension in childhood diseases. In: Avner ED, Harmon W, Niaudet P, Yoshikawa N, editors. Pediatric nephrology. Berlin: Springer-Verlag; 2009. p. 1519–40. A comprehensive review on evaluation of hypertension in children. The review also proposes a practical approach to hypertension evaluation in children.
Flynn J, Zhang Y, Solar-Yohay S, Shi V. Clinical and demographic characteristics of children with hypertension. Hypertension. 2012;60(4):1047–54. Epub 2012/08/16.
Boneparth A, Flynn JT. Evaluation and treatment of hypertension in general pediatric practice. Clin Pediatr. 2009;48(1):44–9. Epub 2008/10/04.
Mutyala K, Baracco R, Kapur G, Mattoo T. Initial evaluation of hypertension in children by primary care physicians. Presented at Pediatric Academic Societies Meeting Boston, USA; April 28-May 1, 2012.
Tullus K. Secondary forms of hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 357–74.
Swinford RD, Portman RJ. Evaluation of the hypertensive pediatric patients. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. p. 499–516.
Chen X, Wang Y. Tracking of blood pressure from childhood to adulthood: a systematic review and meta-regression analysis. Circulation. 2008;117(25):3171–80.
Shear CL, Burke GL, Freedman DS, Berenson GS. Value of childhood blood pressure measurements and family history in predicting future blood pressure status: results from 8 years of follow-up in the Bogalusa Heart Study. Pediatrics. 1986;77(6):862–9.
Daniels SR, Kimball TR, Morrison JA, Khoury P, Meyer RA. Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol. 1995;76(10):699–701.
de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol. 1995;25(5):1056–62.
Sorof JM, Cardwell G, Franco K, Portman RJ. Ambulatory blood pressure and left ventricular mass index in hypertensive children. Hypertension. 2002;39(4):903–8.
Daniels SR, Loggie JM, Khoury P, Kimball TR. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension. Circulation. 1998;97(19):1907–11.
Sheps SG, Frohlich ED. Limited echocardiography for hypertensive left ventricular hypertrophy. Hypertension. 1997;29(2):560–3.
• Singh A, Satchell SC. Microalbuminuria: causes and implications. Pediatr Nephrol. 2011;26(11):1957–65. An update on microalbuminuria in children.
Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009;18(3):246–51. Epub 2009/03/12.
Assadi F. Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol. 2008;29(3):580–4. Epub 2007/11/30.
Burgert TS, Dziura J, Yeckel C, Taksali SE, Weiss R, Tamborlane W, et al. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors. Int J Obes (Lond). 2006;30(2):273–80.
Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362–74.
Haffner SM, Gonzales C, Valdez RA, Mykkanen L, Hazuda HP, Mitchell BD, et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia. 1993;36(10):1002–6.
Daniels SR, Lipman MJ, Burke MJ, Loggie JM. The prevalence of retinal vascular abnormalities in children and adolescents with essential hypertension. Am J Ophthalmol. 1991;111(2):205–8.
Mitchell P, Cheung N, de Haseth K, Taylor B, Rochtchina E, Islam FM, et al. Blood pressure and retinal arteriolar narrowing in children. Hypertension. 2007;49(5):1156–62.
Skalina ME, Annable WL, Kliegman RM, Fanaroff AA. Hypertensive retinopathy in the newborn infant. J Pediatr. 1983;103(5):781–6.
Enright PL, Goodwin JL, Sherrill DL, Quan JR, Quan SF. Blood pressure elevation associated with sleep-related breathing disorder in a community sample of white and Hispanic children: the Tucson Children's Assessment of Sleep Apnea study. Archives Pediatr Adolesc Med. 2003;157(9):901–4.
Marcus CL, Greene MG, Carroll JL. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med. 1998;157(4 Pt 1):1098–103.
Quan SF, Gersh BJ. Cardiovascular consequences of sleep-disordered breathing: past, present and future: report of a workshop from the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute. Circulation. 2004;109(8):951–7.
Mindell J, Owens JA. A Clinical Guide to Pediatric Sleep: Diagnosis and Management of Sleep Problems. Philadelphia, PA: Lippincott, Williams & Wilkins; 2003. p. 10.
Kirk V, Midgley J, Giuffre M, Ronksley P, Nettel-Aguirre A, Al-Shamrani A. Hypertension and obstructive sleep apnea in Caucasian children. World J Cardiol. 2010;2(8):251–6.
Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. Br Med J. 1975;4(5992):316–9.
• Tullus K, Brennan E, Hamilton G, Lord R, McLaren CA, Marks SD, et al. Renovascular hypertension in children. Lancet. 2008;371(9622):1453–63. Recommendations for diagnosis of renovascular hypertension in children, detailing clinical presentation, imaging modalities and treatment.
Mulatero P, Verhovez A, Morello F, Veglio F. Diagnosis and treatment of low-renin hypertension. Clin Endocrinol. 2007;67(3):324–34.
Egan BM, Basile JN, Rehman SU, Davis PB, Grob 3rd CH, Riehle JF, et al. Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial. Am J Hypertens. 2009;22(7):792–801.
Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens. 2001;14(2):186–94.
•• Marks SD, Tullus K. Update on imaging for suspected renovascular hypertension in children and adolescents. Curr Hypertens Rep. 2012;14(6):591–5. Review evaluating current imaging modalities available for children suspected of having renovascular hypertension.
Eklof H, Ahlstrom H, Magnusson A, Andersson LG, Andren B, Hagg A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47(8):764–74.
Li JC, Wang L, Jiang YX, Dai Q, Cai S, Lv K, et al. Evaluation of renal artery stenosis with velocity parameters of Doppler sonography. J Ultrasound Med: Off J Am Inst Ultrasound Med. 2006;25(6):735–42.
Ahmed M, Eggleston D, Kapur G, Jain A, Valentini RP, Mattoo TK. Dimercaptosuccinic acid (DMSA) renal scan in the evaluation of hypertension in children. Pediatr Nephrol. 2008;23(3):435–8.
Simoes e Silva AC, Silva JM, Diniz JS, Pinheiro SV, Lima EM, Vasconcelos MA, et al. Risk of hypertension in primary vesicoureteral reflux. Pediatr Nephrol. 2007;22(3):459–62.
Stokland E, Hellstrom M, Jakobsson B, Sixt R. Imaging of renal scarring. Acta Paediatr Suppl. 1999;88(431):13–21.
Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073:30–7.
Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension. J Clin Hypertens (Greenwich). 2006;8(8):596–9.
• Ingelfinger J. Monogenic and polygenic genetic contributions to hypertension. In: Flynn JT, Ingelfinger JR, Portman RJ, editors. Pediatric hypertension. New York: Humana Press; 2011. An updated review on monogenic hypertension and diagnostic strategies for theses disorders.
Kuo CF, See LC, Yu KH, Chou IJ, Chiou MJ, Luo SF. Significance of serum uric acid levels on the risk of all-cause and cardiovascular mortality. Rheumatology (Oxford). 2013;52(1):127–34.
Niskanen LK, Laaksonen DE, Nyyssonen K, Alfthan G, Lakka HM, Lakka TA, et al. Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med. 2004;164(14):1546–51.
Feig DI, Johnson RJ. The role of uric acid in pediatric hypertension. J Renal Nutr: Off J Counc Renal Nutr Natl Kidney Found. 2007;17(1):79–83.
Johnson RJ, Sanchez-Lozada LG, Mazzali M, Feig DI, Kanbay M, Sautin YY. What are the key arguments against uric Acid as a true risk factor for hypertension? Hypertension. 2013;61(5):948–51.
Reyes AJ, Leary WP. The increase in serum uric acid induced by diuretics could be beneficial to cardiovascular prognosis in hypertension: a hypothesis. J Hypertens. 2003;21(9):1775–7.
Waring WS, Convery A, Mishra V, Shenkin A, Webb DJ, Maxwell SR. Uric acid reduces exercise-induced oxidative stress in healthy adults. Clin Sci (Lond). 2003;105(4):425–30.
Agabiti-Rosei E, Mancia G, O'Rourke MF, Roman MJ, Safar ME, Smulyan H, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension. 2007;50(1):154–60.
Flynn JT. Evaluation and management of hypertension in childhood. Prog Pediatr Cardiol. 2001;12(2):177–88.
Compliance with Ethics Guidelines
Conflict of Interest
Gaurav Kapur has received research funding from Genzyme.
Rossana Baracco declares that she has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kapur, G., Baracco, R. Evaluation of Hypertension in Children. Curr Hypertens Rep 15, 433–443 (2013). https://doi.org/10.1007/s11906-013-0371-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11906-013-0371-2
Keywords
- Hypertension
- Primary hypertension
- Secondary hypertension
- Evaluation
- Children
- Stage 1 hypertension
- Stage 2 hypertension
- Reno-vascular hypertension
- Workup
- Renal ultrasonography
- Renin
- PRA
- Monogenic hypertension
- Microalbuminuria
- Baseline evaluation
- Echocardiography
- High blood pressure
- BP
- Low renin hypertension
- ABPM
- BP measurement
- Pediatric hypertension